baber/WOPTO huggingface dataset:
Patent DE-69723289-D1 (DE)
Inventor: KOZMA L
IPC: C08L91/00
Filed: 1997-11-12
Granted: 2003-08-07
Abstract: Open cell foamed articles including silane-grafted single-site initiated polyolefin resins are described. The single-site initiated olefin polymer resin can be a polyethylene, a copolymer of ethylene, a C3-C20 alpha-olefin, or a copolymer of ethylene, a C3-C20 alpha-olefin and a C4-C20 diene. The open cell foamed articles have good cushioning properties and can be non-allergenic.
Patent DE-69726558-D1 (DE)
Inventor: DUARTE VIEIRA FRANCISCO JOSE
IPC: G09F13/24
Filed: 1997-05-19
Granted: 2004-01-15
Abstract: The present device relates to an advertising device which simulates the bubbling formed in a glass container containing a sparkling beverage. The device comprises a transparent container in the shape of a glass with a lid thereon, the container having a hydro-alcoholic solution in the color of the product to be advertised. To create the bubbles, a closed circuit inert gas system (such as nitrogen) having a compressor, a check valve and a cyclone separator for separating the gas from an entrapped liquid is provided. The system has a first tube with a bubblier attached thereto for injecting micro-bubbles into the container, a second tube for capturing the inert gas at the surface of the liquid in the container, and a third tube for returning the liquid sprayed by the gas back into the container liquid. A panel is preferably provided on which the container is positioned, wherein a back-lighting device and intermittent lights that flash at a rate controlled by a timer can be provided to illuminate the device. The timer preferably controls the compressor so that the input of micro-bubbles into the container, and the operation of the lights, can be synchronized.
Patent DE-69735601-D1 (DE)
Inventor: BOXER G
IPC: G01N27/26
Filed: 1997-11-26
Granted: 2006-05-18
Abstract: A surface detector array device suitable for use with a biosensor is disclosed. The device is formed of a substrate having a surface defining a plurality of distinct bilayer-compatible surface regions separated by one or more bilayer barrier regions. The bilayer-compatible surface regions carry on them, separated by a film of aqueous, supported fluid bilayers. The bilayers may contain selected receptors or biomolecules. A bulk aqueous phase covers the bilayers on the substrate surface.
Patent DE-69737532-D1 (DE)
Inventor: KLEINBERG ISRAEL
IPC: A23L29/00
Filed: 1997-10-23
Granted: 2007-05-10
Abstract: The present invention relates to an oral composition containing a zinc compound containing free available zinc ion and at least one stabilized or stable E<SUB>h </SUB>raising compound distributed in an oral vehicle. The present invention further relates to a method of inhibiting the formation of sulfur containing anions and preventing a reduction in the E<SUB>h </SUB>of the oral cavity. A method of reducing oral malodor and gingivitis and periodontitis is also provided by this invention.
Patent DE-69738517-D1 (DE)
Inventor: SCHULTZ ROGER
IPC: H04M7/00
Filed: 1997-12-16
Granted: 2008-03-27
Abstract: The present invention concerns a method and an apparatus for designing, providing and managing customer services in a telecommunications network. The services are handled in a separate service network, connected to the telecommunications network in a logical service means, for example an SCP in an intelligent network. The service network is based on existing and commonly available network resources, for example, the Internet. Also, existing and commonly available terminals, such as personal computers are used for handling the services.
Patent DE-69739172-D1 (DE)
Inventor: YOUNG ANDREW A
IPC: A61P1/00
Filed: 1997-08-08
Granted: 2009-01-29
Abstract: A pharmaceutical composition comprising an exendin-4 peptide comprising the amino acid sequence HGEGTFTSDL SKQMEEEAVR LFIEWLKNGG PSSGAPPPS in an amount from 0.001 mg to 1 mg based on a 70 kg patient; a pharmaceutically acceptable buffer; a pharmaceutically acceptable isotonicity agent; and a pharmaceutically acceptable carrier.
Patent DE-69809918-D1 (DE)
Inventor: DROEGE R
IPC: B41J2/175
Filed: 1998-07-23
Granted: 2003-01-16
Abstract: This invention relates to a replaceable ink container or bottle (1) for an ink jet printing apparatus in which the mouth of the bottled is closed by a puncturable diaphragm (19). A puncturing member (35) carried by the ink reservoir (21) of the ink jet printing apparatus pierces through the diaphragm upon the container being installed in the ink jet printing apparatus. Upon the puncturing member (35) puncturing through the diaphragm (19), the diaphragm sealingly engages the sides of the puncturing tube so as to substantially prevent the ink from leaking therepast, and the puncturing tube opens communication between the ink within the container and the ink reservoir thereby permitting ink to flow from the bottle into the ink reservoir via the puncturing member. An air path (37) is provided which is in communication with the atmosphere and with the reservoir so that ink from within the container and atmospheric air may be exchanged via the puncturing member so that ink is free to flow from the container into the reservoir, and so that the pressure within the container is maintained substantially at atmospheric pressure. A method of supplying ink to such an ink jet printing apparatus also is disclosed.
Patent DE-69810962-D1 (DE)
Inventor: BROWN MARTIN
IPC: C07D521/00
Filed: 1998-11-17
Granted: 2003-02-27
Abstract: A process for preparing a compound of Formula (I); where Q completes an optionally substituted 5-or 6-member saturated carbocyclic ring and R is optionally substituted phenyl or optionally substituted C3-C6 cycloalkyl which comprises the rearrangement of a compound of Formula (II); where Q and R are as defined in relation to Formula (I) in a polar aprotic, dipolar aprotic or aromatic hydrocarbon solvent in the presence of a moderate base and an azole.
Patent DE-69819959-D1 (DE)
Inventor: PANSERI PIETRO
IPC: C07D317/48
Filed: 1998-05-01
Granted: 2004-01-08
Abstract: Process for the preparation of aromatic compounds containing a heterocyclic system, having general formula (II): <CHEM> which comprises reacting catechol, optionally substituted, with a methylene dihalide in a basic environment and in the presence of a solvent medium consisting of N-methylpyrrolidone.
Patent DE-69826261-D1 (DE)
Inventor: D JANG ARTHUR H K
IPC: A01N65/00
Filed: 1998-03-19
Granted: 2004-10-21
Abstract: Provided is an herbal extract-based composition comprising an extract of Gynostemma pentaphyllum, an extract of Crataegus pinnatifida (hawthorn leaves or berries), and an extract of Camellia sinensis (green tea). Also provided is a process for preparing a herbal extract-based composition which comprises separately extracting each of hawthorn berries, green tea leaves, and Gynostemma pentaphyllum leaves; drying extraction eluates obtained from the extracting of each of hawthorn berries, green tea leaves, and Gynostemma pentaphyllum leaves to obtain organic residues in forming a hawthorn berry extract powder, green tea extract powder, and a Gynostemma pentaphyllum extract powder; and combining the green tea extract powder, the Gynostemma pentaphyllum extract powder, and the hawthorn berry extract powder in desired proportions to form the herbal extract-based composition which has health promoting effects including potent inhibition of free radicals.
Patent DE-69830312-D1 (DE)
Inventor: REFF E
IPC: C12N15/09
Filed: 1998-03-09
Granted: 2005-06-30
Abstract: A method for achieving site specific integration of a desired DNA at a target site in a mammalian cell via homologous recombination is described. This method provides for the reproducible selection of cell lines wherein a desired DNA is integrated at a predetermined transcriptionally active site previously marked with a marker plasmid. The method is particularly suitable for the production of mammalian cell lines which secrete mammalian proteins at high levels, in particular immunoglobulins. Novel vectors and vector combinations for use in the subject cloning method are also provided.
Patent DE-69832498-D1 (DE)
Inventor: THORNE L
IPC: A61M5/31
Filed: 1998-09-03
Granted: 2005-12-29
Abstract: Parts which may be integrally molded with a phlebotomy barrel or with a Luer fitting to provide, in a single molded part, an extendable safety enclosure for a medical cannula in phlebotomy, syringe and other general medical needle applications. Integrally molded part phlebotomy safety devices are disclosed which require only the integrally-molded part, a medical needle, a label and a transport needle cover to form a ready-to-use phlebotomy device. Upon removal of the label and needle cover, the device is ready for use in a medical procedure. The enclosure comprises a plurality of rigid segments serially connected by a plurality of intersegment hinges, which are preferably living hinges. The segments are disposed about a medical needle, folded upon each other during the medical procedure and extended at the end of the procedure to form a secure, substantially rigid safety shroud. During the procedure, the enclosure is folded and conveniently disposed about a proximal portion of the needle. At the end of the procedure, the enclosure is extended to protectively sheath and secure the needle in a substantially rigid structure formed in combination by the enclosure and the needle.
Patent DE-69832712-D1 (DE)
Inventor: MAGNUS-MILLER LESLIE
IPC: A61K31/22
Filed: 1998-08-18
Granted: 2006-01-12
Abstract: The present invention is directed to novel combinations of anti-epileptic compounds that demonstrate pain alleviating properties, with compounds selected from the group consisting of analgesics, NMDA receptor antagonists, and NSAIDs and pharmaceutical compositions comprising same. It has been discovered that the administration of anti-epileptic compounds that demonstrate pain alleviating properties in these novel combinations results in an improved reduction in the frequency and severity of pain. It is also believed that the incidence of unwanted side effects can be reduced by these novel combinations in comparison to using higher doses of a single agent treatment to achieve a similar therapeutic effect. The present invention is also directed to methods of using effective amounts of the novel pharmaceutical compositions to treat pain in mammals.
Patent DE-69839620-D1 (DE)
Inventor: NOSU TSUTOMU
IPC: C08L51/00
Filed: 1998-10-19
Granted: 2008-07-31
Abstract: A composition comprising:     (i) a thermoplastic resin; (ii) from 30 to 70% by weight, based on the resin composition, of magnesium hydroxide having a specific surface area of 20 m<2>/g or less and an average secondary particle diameter of 0.2 to 5.0  mu m, at least a part of the magnesium hydroxide being surface-treated with at least one surface-treating agent; and (iii) from 1 to 20% by weight, based on the resin composition, of a reaction type compatabilizing agent,     the or each surface-treating agent being selected from:     (a) a water-soluble silane-coupling agent;   (b) a phosphoric acid ester of the formula Ä2Ü, <CHEM> wherein R is an alkyl group or alkenyl group which has from 1 to 24 carbon atoms, n is an integer of from 0 to 6, m is 1 or 2, A is an alkylene group having from 2 to 4 carbon atoms and M is an alkali metal, an alkyl amine cation having from 1 to 4 carbon atoms or an alkanolamine cation of the formula Ä3Ü, Ä(R')3-rN-(B-OH)rÜ<+> wherein R' is a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms, B is an alkylene group having from 2 to 4 carbon atoms and r is an integer of from 1 to 3; and (c) a higher fatty acid and/or an alkali metal salt thereof.
Patent DE-69901779-D1 (DE)
Inventor: GASKIN JOHN GRAHAM
IPC: B41F16/00
Filed: 1999-07-30
Granted: 2002-07-18
Abstract: A method of producing a registrable visible image on two or substantially flat articles includes providing substantially flat articles of predetermined shape having at least two edges, providing a sublimation transfer carrier sheet having a predetermined mirror image on an area of said carrier sheet, providing edge templates adjacent the area, each of the edge templates being arranged to abut a corresponding edge of the predetermined shape, placing one of the articles and a sublimation transfer carrier sheet on a a support surface and arranging the area of the carrier sheet such that the mirror substantially covers the predetermined shape with each of the two edges abutting a respective one of the edge templates, allowing sublimation transfer of the image, removing the carrier sheet and the edge templates so as to leave a predetermined visible image within the shape, and repeating the steps with at least one more article which can be arranged in register with the first article.
Patent DE-69909970-D1 (DE)
Inventor: BOHME ANDREES
IPC: A61P43/00
Filed: 1999-02-03
Granted: 2003-09-04
Abstract: A method for the prevention or treatment of cerebellar dysfunction, particularly cerebellar ataxia, by the use of riluzole or a pharmaceutically acceptable salt thereof.
Patent DE-69917800-D1 (DE)
Inventor: HEDBLOM P
IPC: E01F9/04
Filed: 1999-08-03
Granted: 2004-07-08
Abstract: The articles of the present invention comprise pavement marking articles which are retroreflective under dry and/or wet conditions. The articles comprise a monolayer of exposed-lens optical elements, a spacing layer, and a reflective layer. The present invention also provides a method of making said pavement marking articles.
Patent DE-69920923-D1 (DE)
Inventor: TSUCHIYA NAOKI
IPC: C07C323/41
Filed: 1999-07-23
Granted: 2004-11-11
Abstract: The present invention relates to an anthranilic acid derivative expressed by the following formula (1) or the following formula (2), or its pharmacologically permissible salt or solvate. <CHEM>
Patent DE-69921083-D1 (DE)
Inventor: NIYOGI G
IPC: C08F255/04
Filed: 1999-07-29
Granted: 2004-11-18
Abstract: The thermal oxidative stability of acrylic grafted polymers is improved by (a) graft polymerizing monomers selected from the group consisting of (i) an ester or salt of an unsubstituted or 1-3 C alkyl-substituted acrylic acid and (ii) an ester or salt of an unsubstituted or 1-3 C alkyl-substituted acrylic acid and about 1 to about 10 mole %, based on the total monomers added, of an unsubstituted or 1-3 C alkyl-substituted acrylic acid, to a backbone of a propylene polymer material in the presence of a 4-vinyl-substituted 5-12 C cyclic 1-alkene, wherein the total amount of polymerized monomer is about 20 to about 200 parts per hundred parts of the propylene polymer material and the vinyl-substituted cyclic alkene is present in an amount of about 1 mole % to about 30 mole %, based on the total moles of monomer added, and (b) removing any unreacted grafting monomer from the resulting grafted propylene polymer material, decomposing any unreacted initiator, and deactivating any residual free radicals in the material, wherein steps (a) and (b) are carried out in a substantially non-oxidizing environment.
Patent DE-69921537-D1 (DE)
Inventor: CONTE GINO
IPC: A63C17/00
Filed: 1999-05-03
Granted: 2004-12-09
Abstract: An in-line roller skate of the type which includes a shell with a support for the wheels and a quarter which is slidingly associated with the shell. A means for the selective axial movement of the quarter is associated with the shell of the skate. <IMAGE>
Patent DE-69922516-D1 (DE)
Inventor: ANDERSSON MATTS
IPC: A61C5/77
Filed: 1999-09-08
Granted: 2005-01-13
Abstract: A dental product is produced from material in powder form. In a first manufacturing stage, the product is given a shape which is larger than its final shape, and in further manufacturing stages the product is subjected to material shrinkage, sintering and working in order to obtain its final shape. Metal powder is applied to the mold tool, and the mold tool with the applied metal powder is placed in pressure-generating equipment where the powder applied to the mold tool is subjected to compaction pressure which compacts the powder so that at least 80% basic density is obtained in the material. The compacted material is then machined. After machining, the compacted material is removed from the mold tool. The sintering stage is then carried out so that the final shape is obtained.
Patent DE-69923372-D1 (DE)
Inventor: FORNARO EDOARDO
IPC: A62D3/00
Filed: 1999-05-13
Granted: 2005-03-03
Abstract: Use of chitin and/or derivatives thereof as biocatalysts or biostimulators to stimulate, accelerate, enhance and protect the growth of microorganism and a method for the bioremediation of soils and fluids contaminated by organic compounds, comprising the addition of chitin and/or derivatives thereof to said soils and fluids.
Patent DE-69923458-D1 (DE)
Inventor: NASTASIA MARTIN
IPC: C12G1/02
Filed: 1999-02-26
Granted: 2005-03-03
Abstract: A fermentation device and a method for making a substance using the device are provided. The fermentation bung may have an outer plug that includes a central inner annular hole and a one or more holes surrounding the central hole, the outer plug fitting within a bung hole in a barrel in which a substance is going to be fermented. The device may further include an inner plug with a centrally extending stem that frictionally fits into the central inner annual hole of the outer plug to secure the inner plug into the outer plug and also have a top portion which covers the one or more holes surrounding the central hole. During the fermentation of the substance, the gases produced during fermentation may be vented through the device since the top portion of the inner plug may flex slightly to permit the escape of the gas. However, the device prevents any ambient air from entering the barrel since the top portion of the inner plug is covering the one or more holes.
Patent DE-69923535-D1 (DE)
Inventor: DE LA FUENTE MORATA JUAN PEDRO
IPC: C07D277/60
Filed: 1999-03-03
Granted: 2005-03-10
Abstract: Procedure for the preparation of dioxopenicillanic acid derivatives and its salts pharmaceutically acceptable with general formula I, where, R is hydrogen, alkyl group containing 1 to 5 Carbon atoms or a residue of type -CH2R ', where R ' is hydrogen, halogen or a p-toluensulfonyl group. These are prepared by treatment of the compounds of general formula II, where R is as previously defined and X may be hydrogen or bromine, with a metallic reagent constituted by a mixture or alloy of copper and/or cobalt and/or manganese with iron and/or nickel in an aqueous/organic medium. These compounds are useful as inhibitors of beta-lactamase. <CHEM>
Patent DE-69934306-D1 (DE)
Inventor: EGAN D
IPC: A61F2/08
Filed: 1999-04-13
Granted: 2007-01-18
Abstract: An expandable soft tissue fixation assembly for use in anchoring soft tissue to bone. The assembly includes a tab connected to an anchor, a sleeve adapted to surround the anchor, and a flange adapted to hold a soft tissue segment next to a bone. The sleeve is inserted into a blind hole in a bone, and a section of soft tissue is placed over the hole next to the bone. Energy is applied to the flange while a predetermined axial tension is applied to the tab to compress a flared portion of the anchor against the sleeve. An upper tube portion of the anchor and the flange are bonded together, and the applied axial force on the tab separates it from the anchor, leaving the assembly anchored in the bone and the soft tissue section anchored in place between the flange and the bone.
Patent DE-69937759-D1 (DE)
Inventor: GARY KARLIN MICHELSON LOS ANGE
IPC: A61F2/00
Filed: 1999-10-29
Granted: 2008-01-24
Abstract: An interbody spinal fusion implant (20) for insertion across a disc space between adjacent vertebral bodies of a human spine has a body (22) two top side and two bottom side junctions, with at least a pair of diagonally opposed junctions having a distance therebetween that does not significantly exceed the implant body height. The implant (20) also includes one or more bone penetrating protrusions (36) extending outwardly from at least the upper and lower walls of the implant. The implant (20) is inserted on its side (28,28') between adjacent vertebral bodies and then rotated 90 degrees into place. The protrusions (36) penetrate the endplates upon rotation, thereby securing the implant (36) within the spine. The implant (20) has at least one passage (38,38') therethrough from the upper wall (30) to the lower wall (30') to promote fusion through the implant (20). Because of the specialized opposed junctions overdistraction between the adjacent vertebral bodies is avoided when the implant (20) is rotated from an initial insertion position to a final deployed position. <IMAGE>
Patent DE-69938061-D1 (DE)
Inventor: MARKEL ERIC J
IPC: C08F4/642
Filed: 1999-12-15
Granted: 2008-03-13
Abstract: Branched ethylene-propylene compositions which have improved melt strength and shear thinning are provided. The weight average branching index g' for the higher molecular weight region of the ethylene-propylene composition is less than 0.95. Additionally, a novel process is provided for efficiently producing a branched ethylene-propylene composition comprising: a) contacting propylene monomers and ethylene monomers in a reactor with an inert hydrocarbon solvent or diluent and a catalyst composition comprising one or more single site catalyst compounds capable of producing an ethylene-propylene polymer at a temperature from about 50° C. to about 180° C., wherein the ratio in the reactor of the propylene and ethylene monomers to the inert hydrocarbon solvent or diluent is less than 2.0, and further, wherein the propylene and ethylene monomers and the inert hydrocarbon solvent or diluent comprise no more than 90 percent of the total contents of the reactor; and b) recovering a branched ethylene-propylene composition, wherein the weight average branching index g' for the higher molecular weight region of the ethylene-propylene composition is less than 0.95.
Patent DE-69938728-D1 (DE)
Inventor: ALEARDI MASSIMO
IPC: H01R12/57
Filed: 1999-07-28
Granted: 2008-06-26
Abstract: A device including: a board for supporting electronic components and supporting an electric circuit for mutual connection of the electronic components; and at least one terminal for electrically connecting the circuit and a respective insulated electric wire having an inner conductor covered with a coated and/or applied insulating sheath; the terminal being defined by a metal blade forming part of the circuit and which is carried integrally by the board and projects from a first face of the board. The blade is so formed as to define means for mechanically retaining and electrically connecting the electric wire, and which act on an end portion of the inner conductor.
Patent DE-69941546-D1 (DE)
Inventor: LAAYOUN ALI
IPC: C12Q1/682
Filed: 1999-12-17
Granted: 2009-11-26
Abstract: The present invention relates to a process for labeling with signal amplification a ribonucleic acid (RNA), characterized in that it comprises: fragmenting the RNA, fixing a first ligand to the terminal phosphate which is located at the 3' end and/or the 5' end of each fragment of said RNA, said terminal phosphate having been released during the fragmentation, and binding a labeling agent to said first ligand. The invention is preferably applied in the field of medical diagnosis.
Patent DE-502004000911-D1 (DE)
Inventor: STOLZER PAUL
IPC: F16G13/00
Filed: 2004-06-05
Abstract: Chain drive comprises a chain (1) with a section reinforced with a reinforcing part (2) having recesses for receiving the links of the chain parts of the chain. The contour of the recesses corresponds to the outer contour of the links. An independent claim is also included for an operating device for driving components, such as platforms, lifting platforms, cranes, gates and crane trolleys, containing the above chain drive. Preferred Features: The reinforcing part interacts with the links of the chain parts of the chain. The reinforcing part has a linear extension unit.